IP Library Granted Patent US 10,451,623
Granted Patent B2
US 10,451,623 · App. 15/083,427 · Granted Oct 22, 2019

System for chemiluminescence-based detection of methicillin-resistant

Inventors: William Tuchfarber (Amelia, OH); Douglas Harris (Cincinnati, OH); James Marous (South Vienna, OH)
Assignee: NanoDetection Technology, Inc.
G01N33/56938B01L3/5023B01L3/50273B01L3/502715C12Y111/01007G01N21/76G01N33/558B01L2200/025B01L2300/0663B01L2300/0681B01L2300/0867B01L2400/0406B01L2400/0481G01N2021/752G01N2021/757G01N2333/31G01N2333/908G01N2469/10
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,451,623
App. No.
15/083,427
Granted
Oct 22, 2019
Kind
B2
Abstract

The present disclosure comprises a device and accompanying method for determining the presence or absence of Methicillin-resistant Staphylococcus aureus in a sample. The disclosure includes the following elements: (1) a lateral flow strip for microfluidic manipulation of a sample; (2) a cassette device for containing the lateral flow strip and enabling interface with a detection device; (3) a cassette handler; (4) a luminous reagent delivery device; and (5) an electromagnetic radiation detection device capable of converting chemiluminescent radiation from the lateral flow strip into an output for a user.

Claims (8)

1. A cassette device for determining the presence or absence of Methicillin-resistant Staphylococcus aureus (“MRSA”) in a sample, comprising:

(a) a lateral flow strip, comprising (1) a sample acceptor pad for receiving a liquid sample mixed with an enzyme conjugate, (2) a region for accepting a luminous reagent, (3) a region comprising a reaction zone, wherein the reaction zone includes a substance binding region, a negative control region and a positive control region, and (4) an absorbent pump, and wherein (i) the sample acceptor pad, the region for accepting a luminous reagent, the reaction zone, and the absorbent pump are in fluid communication, and facilitate fluid flow in a downstream direction from the sample acceptor pad to the absorbent pump; (ii) the substance binding region includes an antibody for capturing a component of MRSA; (iii) the positive control region includes an antibody for capturing the enzyme conjugate, and (iv) the enzyme conjugate is capable of binding with the component of MRSA and reacting with the luminous reagent, thereby generating electromagnetic radiation; and

(b) a housing, comprising (1) an upper component comprising a first basin for sample preparation, a second basin for sample preparation, a first well for adding a sample, a second well for adding a luminous reagent, a luminous reagent receiving area, a plurality of apertures to allow electromagnetic radiation generated on the lateral flow strip to escape the cassette device wherein the plurality of apertures includes a first aperture corresponding to the substance binding region, a second aperture corresponding to the negative control region, and a third aperture corresponding to the positive control region, a transparent adhesive seal covering the plurality of apertures, the second well, and partially covering the luminous agent receiving area, a plurality of latch receiving regions, a plurality of pressure tabs to contact the lateral flow strip, and a plurality of alignment guides to secure the lateral flow strip in place; (2) a lower component comprising a region upon which the lateral flow strip rests, a sample reservoir, a plurality of alignment guides to secure the lateral flow strip in place, a plurality of latches located complimentary to the latch receiving regions on the upper housing and capable of exerting positive pressure to mechanically latch the upper component and the lower component together, and a plurality of detents for mechanically securing the cassette device in a cassette handler device; (3) an identification label configured to allow electronic identification of the cassette device; and wherein (i) the first well and second well are in fluid communication with the lateral flow strip; (ii) the first well includes a three-sided guide configured to contact the lateral flow strip and direct a flow of sample in the downstream direction; (iii) the luminous agent receiving area includes a first nipple configured to receive the luminous reagent, a channel for transporting the luminous reagent from the nipple to the second well, wherein a surfactant at least partially coats the channel, and a second nipple configured to cause a droplet of luminous reagent to contact the lateral flow strip; and (iv) the apertures include shielding structures configured to direct electromagnetic radiation out of the apertures.

2. The cassette device of claim 1 , wherein the antibody for capturing the component of MRSA is a Penicillin Binding Protein 2a (“PBP2a”) monoclonal antibody.

3. The cassette device of claim 1 , wherein the enzyme conjugate comprises horseradish peroxidase (“HRP”).

4. The cassette device of claim 3 , wherein the antibody for capturing the enzyme conjugate is an IgG antibody.

5. The cassette device of claim 1 , wherein the luminous reagent is luminol.

6. The cassette device of claim 1 , wherein the lateral flow strip is configured so that one or more of the following are partially or completely overlapping: the sample acceptor pad, the region for accepting a luminous reagent, the reaction zone, and the absorbent pump.

Assignments (1)
NUNC PRO TUNC ASSIGNMENT Recorded Sep 24, 2019
From: TUCHFARBER, WILLIAM; HARRIS, DOUGLAS; MAROUS, JAMES
To: NANODETECTION TECHNOLOGY, INC.
Reel/Frame 050472/0060 →
Continuity (1)
Related Publication 20170285026A1 · Oct 5, 2017